Reuters -- A federal judge has granted preliminary approval for Bristol-Myers Squibb Co to pay $125 million to resolve a shareholder lawsuit accusing it of hiding information related to a case involving its anti-blood clotting medication Plavix.
Reuters -- A federal judge has granted preliminary approval for Bristol-Myers Squibb Co to pay $125 million to resolve a shareholder lawsuit accusing it of hiding information related to a case involving its anti-blood clotting medication Plavix.
